FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 29 filers reported holding FUSION PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,485 | -44.3% | 1,725,000 | 0.0% | 0.19% | -23.2% |
| Q2 2023 | $8,056 | +8.2% | 1,725,000 | -12.7% | 0.25% | -43.4% |
| Q1 2023 | $7,446 | +215.1% | 1,975,000 | +163.3% | 0.44% | +234.8% |
| Q4 2022 | $2,363 | -99.9% | 750,000 | 0.0% | 0.13% | +37.5% |
| Q3 2022 | $2,258,000 | +20.9% | 750,000 | 0.0% | 0.10% | -4.0% |
| Q2 2022 | $1,868,000 | -67.9% | 750,000 | 0.0% | 0.10% | -59.0% |
| Q1 2022 | $5,828,000 | +86.3% | 750,000 | 0.0% | 0.24% | +187.1% |
| Q4 2021 | $3,128,000 | -47.3% | 750,000 | 0.0% | 0.08% | -36.1% |
| Q3 2021 | $5,940,000 | -2.0% | 750,000 | 0.0% | 0.13% | +8.1% |
| Q2 2021 | $6,060,000 | +4.8% | 750,000 | +39.1% | 0.12% | +20.6% |
| Q1 2021 | $5,781,000 | – | 539,264 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,543,342 | 3.52% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,664,303 | 2.68% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $4,058,553 | 1.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,354,258 | $3,521,071 | 0.64% |
| Avidity Partners Management LP | 5,781,850 | $15,032,810 | 0.60% |
| Eagle Health Investments LP | 579,769 | $1,507,399 | 0.33% |
| Perceptive Advisors | 2,751,395 | $7,153,627 | 0.24% |
| Ghost Tree Capital, LLC | 243,287 | $632,546 | 0.21% |
| Sio Capital Management, LLC | 246,036 | $639,694 | 0.20% |
| Artal Group S.A. | 1,725,000 | $4,485 | 0.19% |